Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
argenx BV

FDA Inspection

•argenx BV•March 6, 2026

FDA Inspection 1307164 - argenx BV - March 06, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns argenx BV, with an inspection on March 6, 2026, issued by the New England District Office, covering human drugs.

Company: argenx BV
Inspection Date: March 6, 2026
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · a41eae46-82c1-446e-b8be-59e9aeee5df4

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1307164 - argenx BV - March 06, 2026 | Global Key Solutions